Related references
Note: Only part of the references are listed.Rifaximin Resistance in Escherichia coli Associated with Inflammatory Bowel Disease Correlates with Prior Rifaximin Use, Mutations in rpoB, and Activity of Phe-Arg-β-Naphthylamide-Inhibitable Efflux Pumps
Vishesh Kothary et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Inflammation and hepatic encephalopathy
Iona Coltart et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2013)
Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis
Jiannis Vlachogiannakos et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy
Jasmohan S. Bajaj et al.
PLOS ONE (2013)
Ascitic Microbiota Composition Is Correlated with Clinical Severity in Cirrhosis with Portal Hypertension
Geraint B. Rogers et al.
PLOS ONE (2013)
High Prevalence of Antibiotic-Resistant Bacterial Infections Among Patients With Cirrhosis at a US Liver Center
Puneeta Tandon et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Spontaneous bacterial peritonitis: recent guidelines and beyond
R. Wiest et al.
GUT (2012)
Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study
Javier Fernandez et al.
HEPATOLOGY (2012)
Effects of Rifaximin on Bacterial Translocation in Thioacetamide-Induced Liver Injury in Rats
Murat M. M. Harputluoglu et al.
INFLAMMATION (2012)
The Role of Rifaximin in the Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Patients With Liver Cirrhosis
Mohamad A. Hanouneh et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
Periodontal health status and bacteraemia from daily oral activities: systematic review/meta-analysis
Inmaculada Tomas et al.
JOURNAL OF CLINICAL PERIODONTOLOGY (2012)
Intestinal decontamination inhibits TLR4 dependent flbronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice
Qiang Zhu et al.
JOURNAL OF HEPATOLOGY (2012)
Rifaximin vs conventional oral therapy for hepatic encephalopathy: A meta-analysis
Karim M. Eltawil et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Bacterial infections other than spontaneous bacterial peritonitis in cirrhosis
Chalermrat Bunchorntavakul et al.
WORLD JOURNAL OF HEPATOLOGY (2012)
Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis
H. D. Nischalke et al.
JOURNAL OF HEPATOLOGY (2011)
Rifaximin intake leads to emergence of rifampin-resistant staphylococci
Thomas Valentin et al.
JOURNAL OF INFECTION (2011)
A Recent Evaluation of Empirical Cephalosporin Treatment and Antibiotic Resistance of Changing Bacterial Profiles in Spontaneous Bacterial Peritonitis
Tolga Yakar et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Nucleotide-Binding Oligomerization Domain Containing 2 (NOD2) Variants Are Genetic Risk Factors for Death and Spontaneous Bacterial Peritonitis in Liver Cirrhosis
Beate Appenrodt et al.
HEPATOLOGY (2010)
The Human Oral Microbiome
Floyd E. Dewhirst et al.
JOURNAL OF BACTERIOLOGY (2010)
EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis European Association for the Study of the Liver
Pere Gines et al.
JOURNAL OF HEPATOLOGY (2010)
Rifaximin Treatment in Hepatic Encephalopathy
Nathan M. Bass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Severe Sepsis in Cirrhosis
Thierry Gustot et al.
HEPATOLOGY (2009)
Failure of Current Antibiotic First-Line Regimens and Mortality in Hospitalized Patients with Spontaneous Bacterial Peritonitis
A. Umgelter et al.
INFECTION (2009)
Pathogenetic mechanisms of hepatic encephalopathy
D. Haeussinger et al.
GUT (2008)
Experimental and clinical pharmacology of rifaximin, a gastrointestinal selective antibiotic
C Scarpignato et al.
DIGESTION (2006)
Spontaneous bacterial peritonitis with Pasteurella multocida in cirrhosis:: Case report and review of literature
I Tamaskar et al.
SOUTHERN MEDICAL JOURNAL (2004)
Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci
HL DuPont et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Current management of the complications of cirrhosis and portal hypertension: Variceal hemorrhage, ascites, and spontaneous bacterial peritonitis
G Garcia-Tsao
GASTROENTEROLOGY (2001)
In vitro activity and fecal concentration of rifaximin after oral administration
ZD Jiang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
